Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG) (BSIG-173)

Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-IL13 and anti-IL4 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy.

Datasheet INQUIRY

Specifications

Targets

IL13 & IL4

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Idiopathic pulmonary fibrosis

Targets

Target 1

IL13

Gene ID

3596

UniProt ID

P35225

Alternative Names

IL13; interleukin 13; P600; IL-13; interleukin-13

Target 2

IL4

Gene ID

3565

UniProt ID

D4HNR6

Alternative Names

IL4; interleukin 4; BSF1; IL-4; BCGF1; BSF-1; BCGF-1; interleukin-4; binetrakin; pitrakinra; B cell growth factor 1; interleukin 4 variant 2; B_cell stimulatory factor 1; lymphocyte stimulatory factor 1

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG) (BSIG-173). Click the button below to contact us or submit your feedback about this product.

Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-173)

Specifications

Targets

Customer Reviews and Q&As